Skip to Content
Merck
  • Bu4NI-catalyzed, oxidative C(sp2)-C(sp3) cross dehydrogenative coupling for the regioselective direct C-3 benzylation of 2H-indazoles.

Bu4NI-catalyzed, oxidative C(sp2)-C(sp3) cross dehydrogenative coupling for the regioselective direct C-3 benzylation of 2H-indazoles.

Organic & biomolecular chemistry (2020-07-22)
Lalit Yadav, Sandeep Chaudhary
ABSTRACT

A Bu4NI-catalyzed, DTBP-promoted, regioselective C(sp2)-C(sp3) cross dehydrogenative coupling (CDC) protocol for the direct C-3 benzylation of 2H-indazoles is reported. The metal-free protocol is operationally simple and proceeds mechanistically via the generation of stable benzylic free-radicals followed by regioselective addition at the C-3 position of 2H-indazoles which afforded C-3 benzylated 2H-indazoles up to 87% yields. The methodology showed a varied array of functional group tolerance and wide substrate compatibility. The gram-scale synthesis further highlights the importance and versatile nature of this methodology.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Dimethyl 3,3′-dithiopropionimidate dihydrochloride, powder